Technology Transfer

Active Patents

• • Highly stable liposomal fluorescent nanovesicles composed of sterols, quaternary ammonium surfactants and indocyanine green
    Application number: EP26382138
    Application date: 05/02/2026
    
• • Nanovesicles and use thereof in medical diagnosis
    Application number: EP25383341
    Application date: 28/11/2025
    
• • Stimulus-responsive gelable liquid composition comprising vesicles
    Application number: EP24383171
    Application date: 24/10/2024
    Co-owners with Nanomol Technologies SL, Spain 
• • Method for obtaining nanodispersed systems
    Application number: EP24382895
    Application date: 08/09/2024
    Co-owners with Nanomol Technologies SL, Spain and Centro de Investigación Biomédica en Red (CIBER), Spain
• • Vesicles based on glucose-derived surfactants and phytosterols
    PCT publication number: WO/2024/028283
    Priority date: 03/08/2022
    Co-owners with Nanomol Technologies SL, Spain
• • Inverse OPAL hydrogel and its use
    PCT publication number: WO/2023/186794
    Priority date: 29/03/2022
• • Liposomes and its use as enzyme delivery
    Priority number: EP21382062
    PCT publication number: WO/2022/161990
    Priority date: 27/01/2021
    This patent received Orphan Drug Designation from the European Medicines Agency (EMA) in 2021 for the treatment of Fabry disease.
• • A synthetic hydrogel and its use for immunotherapy and 3D-printing
    Priority number: EP20382432
    PCT publication number: WO/2021/234141
    Priority date: 21/05/2020
• • Minimally-invasive continuos clinical monitoring of small molecules with analytical accuracy
    Priority number: US62/936689
    PCT publication number: WO/2021/100042
    Priority date: 18/11/2019
• • Nanovesicles and its use for nucleic acid delivery
    PCT publication number: WO/2020/229469
    Priority date: 15/05/2019
• • Vesicles which include epidermal growth factor and compositions that contain same
    Priority number: CU2012000112
    PCT publication number: WO/2014/019555
    Application date: 02/08/2012
    Licensed to Heber Biotech, Cuba
• • Functionalized liposomes useful for the delivery of bioactive compounds
    Priority number: ES201231020
    PCT publication number: WO/2014/001509
    Priority date: 29/06/2012
• • Method for obtaining micro- and nano-disperse systems
    Priority number: ES200500172
    PCT publication number: WO/2006/079889
    Priority date: 31/01/2005
    Exploited by Nanomol Technologies SL, Spain